查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451864

2024-2032 年按产品、使用类型、价格范围、应用、最终用户和地区分類的血液分析仪和试剂市场报告

Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球血液分析仪和试剂市场规模达到88亿美元。展望未来， IMARC Group预计到2032年市场规模将达到150亿美元，2024-2032年复合年增长率（CAGR）为5.94%。血液疾病盛行率上升、老年人口不断增加、技术快速进步、对即时检测(POCT) 设备和便携式血液分析仪的需求激增，以及实验室和医院越来越多地采用自动化血液分析仪，这些都是其中的一些因素。推动市场的关键因素。

血液分析仪和试剂在现代医学诊断中发挥着至关重要的作用，能够准确、有效率地评估血液样本。它们旨在分析各种血液参数并提供有关患者健康状况的宝贵见解。血液分析仪由几个关键组件组成，包括样本处理系统、流体系统、细胞计数和分化系统以及资料处理单元。与这些分析仪结合使用的试剂有助于促进特定血液成分的检测和测量。血液分析仪在临床环境中具有多种优势，例如可以快速提供结果，从而可以及时做出诊断和治疗决策。此外，它们还提供高水准的准确性和精确度，最大限度地降低诊断错误的风险。它们能够分析各种血液参数，包括全血球计数 (CBC)、白血球分类和血红蛋白水平。目前，有不同类型的血液分析仪可供选择，从紧凑型桌上型型号到大型全自动系统。

血液分析仪和试剂市场趋势：

全球血液分析仪和试剂市场的成长主要受到几个关键因素的推动，包括贫血、白血病和血友病等血液疾病盛行率的上升。此外，老年人口的成长和技术的快速进步，例如血液分析仪中人工智慧（AI）和机器学习（ML）演算法的集成，正在推动市场成长。此外，实验室和医院越来越多地采用自动化血液分析仪，提供快速、精确的结果，正在推动市场成长。人们对早期疾病检测和预防性医疗措施的重要性的认识不断提高，以及对即时检测（POC​​T）设备和便携式血液分析仪的需求激增，是促进市场成长的其他因素。与此一致的是，血液学研发（R＆D）活动的​​支出激增，重点是开发新型试剂和分析仪，正在推动市场成长。此外，主要参与者之间为增强产品组合和扩大地理影响力而进行的策略合作和伙伴关係也有利于市场成长。

本报告回答的关键问题：

  • 迄今为止，全球血液分析仪和试剂市场表现如何，未来几年将如何表现？
  • 全球血液分析仪和试剂市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球血液分析仪和试剂市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的血液分析仪和试剂市场？
  • 基于产品的市场区隔是什么？
  • 血液分析仪和试剂市场中最具吸引力的产品是什么？
  • 根据使用类型分類的市场是怎么样的？
  • 血液分析仪和试剂市场中哪种使用类型最具吸引力？
  • 依价格范围分類的市场是怎么样的？
  • 血液分析仪和试剂市场中哪个价格范围最具吸引力？
  • 基于应用的市场区隔是怎样的？
  • 血液分析仪和试剂市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 血液分析仪和试剂市场中哪一个对最终用户最具吸引力？
  • 全球血液分析仪及试剂市场竞争格局如何？
  • 全球血液分析仪和试剂市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球血液分析仪与试剂市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 血液学
    • 市场走向
    • 市场预测
  • 止血
    • 市场走向
    • 市场预测
  • 免疫血液学
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按使用类型

  • 独立式
    • 市场走向
    • 市场预测
  • 现场护理
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依价格范围

  • 低量程
    • 市场走向
    • 市场预测
  • 中檔
    • 市场走向
    • 市场预测
  • 高范围
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按应用

  • 出血性疾病
    • 市场走向
    • 市场预测
  • 感染相关病症
    • 市场走向
    • 市场预测
  • 免疫系统相关病症
    • 市场走向
    • 市场预测
  • 血癌
    • 市场走向
    • 市场预测
  • 贫血
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 商业服务提供者
    • 市场走向
    • 市场预测
  • 医院实验室
    • 市场走向
    • 市场预测
  • 研究和学术机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Bio-Rad Laboratories Inc.
    • Boule Diagnostics
    • Danaher Corporation
    • Diatron MI PLC (Stratec SE)
    • EKF Diagnostics Holdings plc
    • Heska Corporation
    • Horiba Ltd.
    • Mindray Medical International Limited
    • Nihon Kohden Corporation
    • Siemens
    • Sinnowa Medical Science & Technology Co. Ltd.
Product Code: SR112024A8300

The global hematology analyzers and reagents market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.94% during 2024-2032. Rising prevalence of blood disorders, the growing geriatric population, rapid advancements in technology, surging demand for point-of-care testing (POCT) devices and portable hematology analyzers, and the increasing adoption of automated hematology analyzers in laboratories and hospitals are some of the key factors driving the market.

Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems.

Hematology Analyzers and Reagents Market Trends:

The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hematology analyzers and reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, usage type, price range, application, and end user.

Product Insights:

Haematology

Haemostasis

Immunohaematology

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the product. This includes haematology, haemostasis, and immunohaematology. According to the report, haematology represented the largest segment.

Usage Type Insights:

Standalone

Point-of-Care

A detailed breakup and analysis of the hematology analyzers and reagents market based on the usage type has also been provided in the report. This includes standalone and point-of-care. According to the report, standalone accounted for the largest market share.

Price Range Insights:

Low Range

Mid-Range

High Range

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the price range. This includes low range, mid-range, and high range. According to the report, low range represented the largest segment.

Application Insights:

Haemorrhagic Conditions

Infection-Related Conditions

Immune System-Related Conditions

Blood Cancer

Anaemia

A detailed breakup and analysis of the hematology analyzers and reagents market based on the application has also been provided in the report. This includes haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia. According to the report, haemorrhagic conditions accounted for the largest market share.

End User Insights:

Commercial Service Providers

Hospital Laboratories

Research and Academic Institutes

Others

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the end user. This includes commercial service providers, hospital laboratories, research and academic institutes, and others. According to the report, commercial service providers represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for hematology analyzers and reagents. Some of the factors driving the North America hematology analyzers and reagents market included the surging demand for personalized medicine and companion diagnostics, the increasing number of clinical trials and drug development activities, and the rising demand for hematology analyzers and reagents in veterinary diagnostics.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global hematology analyzers and reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global hematology analyzers and reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hematology analyzers and reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global hematology analyzers and reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive hematology analyzers and reagents market?
  • What is the breakup of the market based on product?
  • Which is the most attractive product in the hematology analyzers and reagents market?
  • What is the breakup of the market based on the usage type?
  • Which is the most attractive usage type in the hematology analyzers and reagents market?
  • What is the breakup of the market based on price range?
  • Which is the most attractive price range in the hematology analyzers and reagents market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the hematology analyzers and reagents market?
  • What is the breakup of the market based on end user?
  • Which is the most attractive end user in the hematology analyzers and reagents market?
  • What is the competitive structure of the global hematology analyzers and reagents market?
  • Who are the key players/companies in the global hematology analyzers and reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hematology Analyzers and Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Haematology
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Haemostasis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunohaematology
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Usage Type

  • 7.1 Standalone
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point-of-Care
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Price Range

  • 8.1 Low Range
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Mid-Range
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 High Range
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Haemorrhagic Conditions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Infection-Related Conditions
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immune System-Related Conditions
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Blood Cancer
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Anaemia
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Commercial Service Providers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospital Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research and Academic Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Boule Diagnostics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Danaher Corporation
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Diatron MI PLC (Stratec SE)
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 EKF Diagnostics Holdings plc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Heska Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Horiba Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Mindray Medical International Limited
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Nihon Kohden Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Siemens
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Sinnowa Medical Science & Technology Co. Ltd.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Hematology Analyzers and Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Hematology Analyzers and Reagents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Hematology Analyzers and Reagents Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Hematology Analyzers and Reagents Market: Breakup by Usage Type (in %), 2023
  • Figure 6: Global: Hematology Analyzers and Reagents Market: Breakup by Price Range (in %), 2023
  • Figure 7: Global: Hematology Analyzers and Reagents Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Hematology Analyzers and Reagents Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Hematology Analyzers and Reagents Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Hematology Analyzers and Reagents (Haematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Hematology Analyzers and Reagents (Haematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Hematology Analyzers and Reagents (Haemostasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Hematology Analyzers and Reagents (Haemostasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Hematology Analyzers and Reagents (Immunohaematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Hematology Analyzers and Reagents (Immunohaematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Hematology Analyzers and Reagents (Standalone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Hematology Analyzers and Reagents (Standalone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Hematology Analyzers and Reagents (Point-of-care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Hematology Analyzers and Reagents (Point-of-care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Hematology Analyzers and Reagents (Low Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Hematology Analyzers and Reagents (Low Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Hematology Analyzers and Reagents (Mid-Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Hematology Analyzers and Reagents (Mid-Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Hematology Analyzers and Reagents (High Range) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Hematology Analyzers and Reagents (High Range) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Hematology Analyzers and Reagents (Haemorrhagic Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Hematology Analyzers and Reagents (Infection-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Hematology Analyzers and Reagents (Immune System-Related Conditions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Hematology Analyzers and Reagents (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Hematology Analyzers and Reagents (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Hematology Analyzers and Reagents (Anaemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Hematology Analyzers and Reagents (Anaemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Hematology Analyzers and Reagents (Commercial Service Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Hematology Analyzers and Reagents (Hospital Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Hematology Analyzers and Reagents (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Hematology Analyzers and Reagents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Hematology Analyzers and Reagents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: United States: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: United States: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Canada: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Canada: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Asia-Pacific: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Asia-Pacific: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: China: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: China: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Japan: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Japan: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: India: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: India: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: South Korea: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: South Korea: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Australia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Australia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Indonesia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Indonesia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Europe: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Europe: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Germany: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Germany: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: France: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: France: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: United Kingdom: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: United Kingdom: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Italy: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Italy: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Spain: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Spain: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Russia: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Russia: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Latin America: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Latin America: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Brazil: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Brazil: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Mexico: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Mexico: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Others: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Others: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Middle East and Africa: Hematology Analyzers and Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Middle East and Africa: Hematology Analyzers and Reagents Market: Breakup by Country (in %), 2023
  • Figure 92: Middle East and Africa: Hematology Analyzers and Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Hematology Analyzers and Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 94: Global: Hematology Analyzers and Reagents Industry: Value Chain Analysis
  • Figure 95: Global: Hematology Analyzers and Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hematology Analyzers and Reagents Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Usage Type (in Million US$), 2024-2032
  • Table 4: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Price Range (in Million US$), 2024-2032
  • Table 5: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Hematology Analyzers and Reagents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Hematology Analyzers and Reagents Market: Competitive Structure
  • Table 9: Global: Hematology Analyzers and Reagents Market: Key Players